Claims filing process made easy
Litigation | Discover Card Excessive Fees Litigation |
---|---|
Settlement Fund | $1.2 Billion |
Class Period | Jan. 1, 2007 – Dec. 31, 2023 |
Description / Eligibility | Companies that accepted Discover at any point during the class period may be eligible in this class action that alleges Discover misclassified certain credit cards and, as a result, charged members inflated interchange fees. |
Litigation | Payment Card Interchange Fees (Visa/Mastercard) |
---|---|
Settlement Fund | $5.54 Billion |
Class Period | Jan. 1, 2004 - Jan. 25, 2019 |
Description / Eligibility | Entities may be an eligible class member if they accepted Visa and/or MasterCard-branded debit and/or credit card payments between January 1, 2004 and January 25, 2019. *The deadline to file claims has elapsed. No-cost assistance is available from the Class Administrator and Class Counsel regarding the settlement. Additional information is available at the Court-approved website, www.paymentcardsettlement.com. |
Litigation | Blue Cross Blue Shield Antitrust Litigation MDL 2406 |
Settlement Fund | $2.8 Billion |
Class Period | Feb. 7, 2008 - Oct. 4, 2024 |
Description / Eligibility | Companies that provided healthcare services, equipment, or supplies in the U.S. to any patient who was insured by a Blue-Branded Commercial Health Benefit Product at any time during the class period. |
Litigation | Prescription Opiates |
Settlement Fund | $378 Million |
Class Period | Jan. 1, 1996 – Sept. 3, 2024 |
Description / Eligibility | Companies that purchased, paid for, and/or reimbursed some or all the cost of opioid prescription drugs, and/or paid or reimbursed for treatments related to misuse, addiction, and/or overdose of opioid drugs on behalf of your members, employees, insureds, participants, or beneficiaries during the class period. |
Litigation | Generic Pharmaceuticals |
Settlement Fund | $733.5 Million |
Class Period | May 1, 2009 – Mar. 5, 2024 |
Description / Eligibility | Companies that purchased, paid for, and/or reimbursed for prescription drugs on behalf of members, employees, insureds, participants, or beneficiaries, and/or companies that dispense drugs (including clinics, hospitals, and independent pharmacies) in the United States may be eligible to recover from one or more of dozens of lawsuits involving the purchase or sale of pharmaceuticals. |
Litigation | Stock Loan Market |
---|---|
Settlement Fund | $580 Million |
Class Period | Jan. 7, 2009 – Aug. 22, 2023 |
Description / Eligibility | Companies who, directly or through an agent, entered into Stock Loan Transactions with the Prime Broker Defendants, direct or indirect parents, subsidiaries, or divisions of the Prime Broker Defendants, or the Released Credit Suisse Parties. |
Litigation | Libor-Based Financial Instruments |
---|---|
Settlement Fund | $196.4 Million |
Class Period | Jan. 1, 2003 – Dec. 15, 2023 |
Description / Eligibility | Companies that transacted in financial instruments tied to the LIBOR-rate during the class period, you may be eligible for recoveries in the $196.4 Million remaining settlements. |
Litigation | Interest Rate Swaps Antitrust Litigation |
---|---|
Settlement Fund | $71 Million |
Class Period | Jan. 1, 2008 – TBD |
Description / Eligibility | Companies who, directly or through an agent, entered into one or more U.S. Interest Rate Swap(s) (“IRS”) Transactions during the class period may be eligible. |
Litigation | Automotive Parts (various) - Direct |
---|---|
Settlement Fund | $113.3 Million |
Class Period | Jan. 1, 1995 – Sept. 18, 2021 |
Description / Eligibility | Companies that purchased certain automotive parts directly from manufacturers during the class period, may be eligible for recoveries from various pending settlements totaling $113.3 million. |
Litigation | Transpacific Airline Travel |
---|---|
Settlement Fund | $90,150,000 |
Class Period | Jan 1, 2000 - Jun 15, 2015 |
Description / Eligibility | Settlement Class All persons and entities that purchased passenger air transportation originating in the United States that included at least one flight segment to Asia or Oceania, from Defendants or their co-conspirators, or any predecessor subsidiary, or affiliate thereof. If your company bought a ticket for air travel between January 1, 2000 and June 15, 2015 that included at least one flight segment between the U.S. and Asia or Oceania, it may be eligible for a recovery in the $90 million settlement so far. |
Litigation | Domestic Airline Travel |
---|---|
Settlement Fund | "$60,000,000* *Partial Settlement" |
Class Period | July 2011 - Jun 14, 2014 |
Description / Eligibility | If your company purchased air passenger transportation service for flights within the United States and its territories beginning July 1, 2011, it may be eligible for recovery. |
Litigation | Prescription Drug Settlements |
---|---|
Settlement Fund | Various |
Class Period | Various |
Description / Eligibility | Companies that directly or indirectly purchased, paid and/or reimbursed prescription drugs on or after January 1, 1999 may be eligible for recoveries in these settlements. |